The Arexvy® vaccine protects people 60 years of age and older against getting respiratory syncytial virus (RSV). RSV is:
- very common in the winter and spring months in Aotearoa New Zealand
- a virus that causes infections of the respiratory tract (lungs), eg, bronchiolitis and pneumonia.
- highly contagious and is spread through droplets from a sneeze or cough.
Read more about RSV.
One dose of the Arexvy vaccine is 80% effective against getting the RSV infection and 94% effective against severe illness from RSV infection.
Arexvy isn't funded by the government. Prices are expected to be $350 or more but will vary, so it's best to check the cost with your healthcare provider before you get vaccinated.